| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a4720294e579980300cc53c33e6426bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cbffa3b81b3b862dc7220b5648f5f745 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2250-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-308 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704 |
| filingDate |
2015-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_641c99d86e03476bb2d88970d82aa383
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34425ccbb50a8e9650e557d836a82c1f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9ec4330b4063cf86aca5fc3ed919c61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_586e893802167b469d46619988b87377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21bf6eedc394cfe614d7402cb2e3caf4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8123820baa72d0fdca7efdf8b4837fbb |
| publicationDate |
2017-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20170057474-A |
| titleOfInvention |
Pharmaceutical composition for treating and inhibiting metastasis of glioblastoma comprising protopanaxadiols compound |
| abstract |
The present invention relates to a pharmaceutical composition and a food composition for inhibiting the metastasis of glioblastoma comprising protopanaxadiol (PPD) or compound-K, which is a ginsenoside compound of panaxadiols, and an effective component. Ginsenoside C-L or PPD provided in the present invention can inhibit the adhesion of cells of glioblastoma, can induce anoikis, and shows cytotoxicity against the cells of glioblastoma, and therefore can be widely utilized in effective treatments for patients with glioblastoma by performing the treatment and the inhibition of the metastasis of glioblastoma at the same time. |
| priorityDate |
2015-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |